Press release
Atrial Fibrillation Drugs Market Size will Observe Substantial Growth by 2027
Atrial Fibrillation Drugs Market: OverviewAtrial fibrillation is the most common sustained cardiac arrhythmia disorder across the globe. It is caused by degeneration of the electrical impulses in the upper cardiac chambers (atria) of the heart leading to chaotic rhythm. Advancing age, diabetes, high blood pressure, obesity, excessive alcohol consumption, chronic kidney disease, and ischemic heart disease are the major risk factors for atrial fibrillation.
Report Overview @ https://www.transparencymarketresearch.com/atrial-fibrillation-drugs-market.html
According to the American Heart Association, the lifetime risk of developing atrial fibrillation is 25% for individuals aged 40 years and above. Atrial fibrillation leads to increased hospitalization rate, impaired quality of life, and increased risk of stroke and death. Atrial fibrillation medications are used to control the heart rate and rhythm by preventing blood clots which leads to effective management of the disease. Warfarin, Apixaban, Sotalol, Esmalol, Verapamil, and Dofetilide are some of the atrial fibrillation drugs currently available in the market.
Atrial Fibrillation Drugs Market: Key Trends
Increase in the number of elderly patients and rise in prevalence of atrial fibrillation across the globe are the major factors driving the global atrial fibrillation drugs market. According to the Centers for Disease Control and Prevention (CDC), 2.7 million to 6.1 million people in the U.S. are suffering from atrial fibrillation and the number is expected to reach 12.1 million by 2030. This is projected to fuel the demand for atrial fibrillation drugs during the forecast period.
Get a Glimpse of the In-Depth Analysis through our Comprehensive "Atrial Fibrillation Drugs Market" Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=66692
Increase in the geriatric population is a major factor contributing to high prevalence of atrial fibrillation, which in turn is anticipated to propel the market in the next few years. For instance, prevalence of atrial fibrillation increases with age, affecting around 10% of the population aged 80 years and above. However, high cost of anticoagulants and complications associated with the use of atrial fibrillation drugs including shortness of breath, low blood pressure, seizures, slow heart rate, fainting, hallucinations, and heart palpitations are likely to restrain the global market from 2019 to 2027.
Atrial Fibrillation Drugs Market: Segmentation
The global atrial fibrillation drugs market can be segmented based on drug class, type, route of administration, end-user, and region. In terms of drug class, the market can be categorized into calcium channel blockers, beta-adrenergic receptor blockers, cardiac glycosides, antiarrhythmic drugs, anticoagulants, and antiplatelet agents. The anticoagulants segment held considerable share of the global market in 2018. Based on type, the global atrial fibrillation drugs market can be divided into paroxysmal, persistent, and long-standing atrial fibrillation. In terms of route of administration, the global market can be bifurcated into oral and injectable. Based on end-user, the global atrial fibrillation drugs can be classified into hospitals, ambulatory surgical centers, and others.
Pre Book "Atrial Fibrillation Drugs Market" Research Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=66692<ype=S
Atrial Fibrillation Drugs Market: Regional Analysis
The global atrial fibrillation drugs market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to account for the largest share of the global market between 2019 and 2027. Rise in prevalence of cardiovascular diseases such as atrial fibrillation among the aging patient pool, presence of leading drug manufacturers in the U.S., and favorable reimbursement scenario for cardiac surgeries are anticipated to drive demand for atrial fibrillation drugs in the country. According to CDC, 9% of the geriatric population aged 65 and above has atrial fibrillation in the country.
High geriatric patient pool with cardiac disorders and rise in prevalence of atrial fibrillation is expected to drive demand for atrial fibrillation therapeutics in Europe in the next few years. For instance, atrial fibrillation affects approximately 4.5 million people in countries in Europe. Rapid adoption of western lifestyle, which increases the risk of cardiac diseases, and surge in the baby boomer population suffering from cardiovascular ailments in the developing countries such as India and China are the key factors boosting the atrial fibrillation drugs market in Asia Pacific.
Atrial Fibrillation Drugs Market: Competitive Landscape
Key players operating in the global atrial fibrillation drugs market are Pfizer, GlaxoSmithKline, Johnson & Johnson, Sanofi, Boehringer Ingelheim Pharmaceuticals, Inc., Daiichi Sankyo Company, Limited, Acesion Pharma, and Bristol-Myers Squibb Co. These players focus on research and development activities for innovative product launches, as well as mergers & acquisitions to expand product portfolio and enhance geographic presence.
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atrial Fibrillation Drugs Market Size will Observe Substantial Growth by 2027 here
News-ID: 1906265 • Views: …
More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth.
Uncover essential discoveries and trends from…

Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth.
Discover essential conclusions and data from our Report in this sample -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100
Analysts' Viewpoint
The Technetium‐99m…

Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine…

Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,…
More Releases for Atrial
Rising Cardiovascular Disease Rates Drive Growth In Atrial Flutter: A Key Driver …
The Atrial Flutter Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Atrial Flutter Market Size and Its Estimated Growth Rate?
In recent times, the market size for atrial flutter has seen swift growth. The market evaluation is expected to rise from $19.92…
Elevated Prevalence Of Atrial Fibrillation Fuels Growth In The Left Atrial Appen …
What Are the Projected Growth and Market Size Trends for the Left Atrial Appendage Closure Device Market?
The left atrial appendage closure device market will grow from $1.67 billion in 2024 to $2 billion in 2025, at a CAGR of 19.5%. The growth is attributed to the rising prevalence of atrial fibrillation, advancements in stroke prevention strategies, clinical evidence and research, minimally invasive alternatives, and a preference for non-pharmacological options.
The left…
Atrial Fibrillation Surgery Devices Market - Restoring Rhythm, Transforming Live …
Newark, New Castle, USA: The "Atrial Fibrillation Surgery Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Atrial Fibrillation Surgery Devices Market: https://www.growthplusreports.com/report/atrial-fibrillation-surgery-devices-market/8777
This latest report researches the…
Atrial Fibrillation Market - Unveiling the Path to a Steady Heart: Advancements …
Newark, New Castle, USA - new report, titled Atrial Fibrillation Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Atrial Fibrillation market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Atrial Fibrillation market. The report offers an overview of the market, which…
Atrial Fibrillation Market Insights, Forecast to 2030
The report extensively examines the global Atrial Fibrillation market while focusing on the leading companies and their business strategies, geographical growth, market segmentation, competitive environment, production, price, and cost structures. Each section of the research report has been carefully designed to examine important facets of the global market for Atrial Fibrillation . For instance, the market dynamics section delves deeply into the trends, opportunities, and drivers influencing the global market…
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…